MC38 cell line and choosing a model system by what it lets you conclude

Choosing and documenting a model

1. Match the line to the host strain. A syngeneic line only grows without rejection in the strain it came from. Using it in another background produces a rejection experiment, which is occasionally the point and usually not.
2. Decide whether the question is target or immune. Human target pharmacology usually needs a human line and an immunodeficient host, which removes the immune system from the model. Immune questions need a competent host and therefore mouse biology. Very few models give both.
3. Use a secreted reporter for longitudinal work. A reporter released into blood or medium allows repeated measurement without sacrificing the animal or the culture, which reduces numbers and increases statistical power.
4. Characterise what the line releases if that is the subject. Vesicles, cytokines and metabolites released by a line are part of its phenotype and vary with confluence and medium. Characterise them under the conditions of the experiment rather than from the literature.
5. Treat array screens as hypothesis generators. A multiplex array indicates which analytes changed and at what approximate magnitude. Confirming with a quantitative assay for the ones that matter is what turns a screen into a result.
6. Document the line as you would a reagent. Source, passage, authentication, screening and the exact growth conditions. Model results that cannot be reproduced usually differ in one of those five.

Every model excludes something

A model is chosen by what it lets you observe, and every choice removes something else. Naming what the model excludes, in the write up, is what keeps the conclusion proportionate.

Where the excluded element is central to the claim, a second model with the opposite trade is the standard answer.

Culture conditions travel with the result

Confluence, medium, serum lot and passage change growth rate, immunogenicity and what a line secretes. Two laboratories using the same line under different conditions are running different experiments.

Record those four alongside the line name. It is the difference between a reproducible model and a familiar one.

A monocyte cell line, and which one to use

The common choices are a monocytic leukaemia line differentiated toward macrophages with phorbol ester, and a histiocytic line used in suspension, and neither is a monocyte: differentiation state, receptor repertoire and cytokine responses all differ from primary cells. They are used because they are renewable and consistent. Where the conclusion is about human myeloid biology, the honest design pairs a line for mechanism with primary monocyte-derived cells for confirmation, and states the differentiation protocol in both cases.

bv2 cells, and what a microglial line can answer

BV2 is a murine microglial line immortalised with a retrovirus, and it is used because primary microglia are hard to obtain and harder to keep. It responds to lipopolysaccharide and other stimuli with cytokine production, which makes it usable for pathway and screening work, and its phenotype is not a primary microglial cell's: the transcriptional response is blunted and some receptors are expressed at different levels. The honest design pairs it for mechanism with primary or stem cell derived microglia for confirmation.

An atf3 antibody and a stress induced factor

ATF3 is induced by many stresses and is otherwise almost absent, so an atf3 antibody reports a condition and an unstimulated lane is what makes a positive meaningful. Several isoforms arise from alternative splicing with opposite transcriptional effects, so the expected masses and the epitope position belong in the method rather than being assumed.

A cebpa antibody and two isoforms from one message

CEBPA is translated into a full length and a shorter isoform with different activity, so a cebpa antibody should show both bands and the ratio is the finding in myeloid biology. Mutations that shift that ratio are disease relevant, which is why the epitope position decides whether a truncated product is detected at all.

Common questions

Why use a syngeneic line?

Because it grows in an immunocompetent animal of the matching strain, which is the only way to study an immune response to a tumour in vivo. The cost is that the biology is mouse rather than human.

Can a human line be used in an immunocompetent host?

No, it is rejected. Human lines require an immunodeficient or humanised host, and that choice removes or reshapes exactly the immune biology a syngeneic model preserves.

Are antibody arrays quantitative?

Semi quantitative at best. They rank and indicate magnitude across many analytes, and anything a conclusion depends on should be confirmed with a validated single analyte assay.

Browse by service class

• Compare Gene synthesis on advertised prices